Compliances -Reg. 24A Annual Secretarial Compliance
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Limited filed its Annual Secretarial Compliance Report for FY 2024-25, prepared by Practicing Company Secretary Riddhi Shah. The company has an authorised capital of Rs. 110 crore. Two non-compliances were flagged: (1) the Board does not have the required minimum of six directors as per Regulation 17(1)(c) of SEBI LODR, since the company falls in the top 2000 listed entities — non-compliance continued from 12 April 2024 till 31 March 2025 and is still ongoing; and (2) the Structured Digital Database (SDD) for recording Unpublished Price Sensitive Information (UPSI) sharing was not updated after 29 October 2024, in breach of SEBI Insider Trading Regulations. The company had previously taken corrective steps on related issues (appointment of directors, NSDL portal updates, PAN freezing for trading windows) but board composition and SDD remain unresolved.
Shareholders should note ongoing corporate governance lapses — an under-strength Board and weak insider-trading controls. These are advisory-level non-compliances with no fines yet, but they could attract regulatory action from SEBI or the stock exchanges if not fixed, and may weigh on investor confidence.